Physical Activity for Reduction of Recurrence Rate After Adjuvant Chemotherapy for Localised Colorectal Carcinoma
2 other identifiers
observational
30
1 country
7
Brief Summary
- feasibility of physical activity
- increase of physical conversation
- Quality of Life (optional)
- vascular and metabolic effects
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2010
Typical duration for all trials
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 23, 2010
CompletedFirst Posted
Study publicly available on registry
September 28, 2010
CompletedStudy Start
First participant enrolled
October 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2013
CompletedResults Posted
Study results publicly available
September 19, 2024
CompletedSeptember 19, 2024
April 1, 2024
2.5 years
September 23, 2010
August 22, 2023
April 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Feasibility of Physical Activity After 12 Weeks (3 Months)
Evaluation of the feasibility measured in terms of training adherence during the first 12 weeks measured in actual participant-weeks in relation to the 360 planned participant-weeks during cycle 1 (week 1 to week 12)
3 months
Feasibility of Physical Activity After 26 Weeks (6 Months)
Evaluation of the feasibility measured in terms of training adherence during the weeks 13 to 26 measured in actual participant-weeks in relation to the planned 420 participant-weeks during cycle 2 (week 13 to week 26)
6 months
Feasibility of Physical Activity After 52 Weeks (12 Months)
Evaluation of the feasibility measured in terms of training adherence during the weeks 27 to 52 measured in actual participant-weeks in relation to the planned 780 participant-weeks during cycle 3 (week 27 to week 52)
12 months
Secondary Outcomes (9)
Exercise Ergometry Activity After 12 Weeks (3 Months)
3 months
Exercise Ergometry Activity After 26 Weeks (6 Months)
6 months
Exercise Ergometry Activity After 52 Weeks (12 Months)
12 months
Adiponectin at Screening
Day 1 (at screening)
Adiponectin After 12 Weeks (3 Months)
3 months
- +4 more secondary outcomes
Study Arms (1)
Physical exercise
No treatment, only physical examinations accompanying physical exercise
Interventions
Eligibility Criteria
subjects with localised colorectal carcinoma
You may qualify if:
- complete resected, histologically confirmed adeno carcinoma of colon or rectal and condition after (neo-)adjuvant therapy either in (1) stage III or (2) stage II with risk factor
- weeks after the end of an adjuvant chemotherapy
- ECOG 0,1
- Age \> 18 years
- adequate liver-, nephro- and hemogram parameters
- physical eligibility
You may not qualify if:
- significant comorbidities which exclude the participation
- evidence of local recurrence or distant metastases
- non-compliance of subject
- other malignancy within the last 5 years (except: skin basalioma, cervix carcinoma in situ)
- clinically significant cardiovascular diseases
- treatment with beta blocker without possibility of adjustment
- left bundle-branch block
- simultaneous chemotherapy or radiotherapy
- pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (7)
Hospital BHB St. Veit/Glan, Surgery
Saint Veit A. D. Glan, Carinthia, 9330, Austria
Medical University Innsbruck, Internal Medicine
Innsbruck, Tyrol, 6020, Austria
District Hospital Kufstein
Kufstein, Tyrol, 6330, Austria
AKH Linz
Linz, Upper Austria, 4020, Austria
Klinikum Wels-Grieskirchen
Wels, Upper Austria, 4600, Austria
State Hospital Rankweil
Rankweil, Vorarlberg, 6830, Austria
Paracelsus Medical University Salzburg-Oncology, Coop. Group
Salzburg, 5020, Austria
Related Publications (8)
Meyerhardt JA, Giovannucci EL, Holmes MD, Chan AT, Chan JA, Colditz GA, Fuchs CS. Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol. 2006 Aug 1;24(22):3527-34. doi: 10.1200/JCO.2006.06.0855. Epub 2006 Jul 5.
PMID: 16822844RESULTMeyerhardt JA, Heseltine D, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, Thomas J, Nelson H, Whittom R, Hantel A, Schilsky RL, Fuchs CS. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol. 2006 Aug 1;24(22):3535-41. doi: 10.1200/JCO.2006.06.0863. Epub 2006 Jul 5.
PMID: 16822843RESULTHolmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA. Physical activity and survival after breast cancer diagnosis. JAMA. 2005 May 25;293(20):2479-86. doi: 10.1001/jama.293.20.2479.
PMID: 15914748RESULTDemark-Wahnefried W. Cancer survival: time to get moving? Data accumulate suggesting a link between physical activity and cancer survival. J Clin Oncol. 2006 Aug 1;24(22):3517-8. doi: 10.1200/JCO.2006.06.6548. Epub 2006 Jul 5. No abstract available.
PMID: 16822842RESULTJackson AS, Pollock ML. Generalized equations for predicting body density of men. Br J Nutr. 1978 Nov;40(3):497-504. doi: 10.1079/bjn19780152.
PMID: 718832RESULTHoeger W, Hoeger S. Principles and Labs for Physical Fitness. Morton Publishing Company, first edition 1999
RESULTO'Donovan G, Owen A, Bird SR, Kearney EM, Nevill AM, Jones DW, Woolf-May K. Changes in cardiorespiratory fitness and coronary heart disease risk factors following 24 wk of moderate- or high-intensity exercise of equal energy cost. J Appl Physiol (1985). 2005 May;98(5):1619-25. doi: 10.1152/japplphysiol.01310.2004. Epub 2005 Jan 7.
PMID: 15640382RESULTHaber Paul. Leitfaden zur medizinischen Trainingsberatung - Rehabilitation bis Leistungssport. 3. Auflage 2009; Springer Wien New York
RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Trial Office Director
- Organization
- ABCSG (Austrian Breast & Colorectal Cancer Study Group)
Study Officials
- STUDY CHAIR
Josef Thaler, MD
Austrian Breast & Colorectal Cancer Study Group
- STUDY CHAIR
Michael Fridrik, MD
Austrian Breast & Colorectal Cancer Study Group
- STUDY CHAIR
Alfred Fridrik, MD
Austrian Breast & Colorectal Cancer Study Group
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 23, 2010
First Posted
September 28, 2010
Study Start
October 1, 2010
Primary Completion
April 1, 2013
Study Completion
April 1, 2013
Last Updated
September 19, 2024
Results First Posted
September 19, 2024
Record last verified: 2024-04